Clinical Trial Update: An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Flotufolastat F-18 PET/CT to detect residual or recurrent disease in patients who completed focal therapy for prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Flotufolastat F-18 (flotufolastat F-18)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Carcinoma | Phase 2 | Status: RECRUITING